Cloud Banner

Healthcare

Image

Global Over the Counter (OTC)/Direct to Consumer (DTC) Infectious Disease Diagnostics Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Jul 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Over the Counter (OTC)/Direct to Consumer (DTC) Infectious Disease Diagnostics Market, By Technology (PCR, Immunodiagnostics, Clinical Microbiology, INAAT, DNA Sequencing and NGS, DNA Microarrays, Others), Disease Type (COVID-19, HIV, HAIs, Hepatitis, CT/NG, HPV, TB, Influenza, Other), End User (Diagnostic Laboratories, Hospitals and Clinics, Academic Research Institutes, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Over the Counter (OTC)/Direct to Consumer (DTC) Infectious Disease Diagnostics Market

Market Analysis and Insights: Global Over the Counter (OTC)/Direct to Consumer (DTC) Infectious Disease Diagnostics Market

Over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 2,331.14 million by 2028 and will grow at a CAGR of 12.23% in the above mentioned forecast period. The rise in the prevalence of infectious diseases and onset of COVID-19 is amongst the important factor expected to intensify the growth and demand of over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market.

Over the Counter (OTC) and Direct to Consumer (DTC) has highly changed the clinical lab testing industry. Infectious diseases are amongst the leading causes of morbidity and mortality across the world. Diagnostics is the main step for the disease discovery and treatment leading to suppression of infectious diseases.

The rise in the focus on R&D and funding in infectious disease diagnostics and rise in the awareness for early disease diagnosis in developing countries are also expected contributes to the growth in the global market over the forecast period of 2021 to 2028. Also the rise in the technological advancements in infectious disease diagnostics and rapid advancements in over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics techniques are also likely to enhance the growth of the market. Furthermore, the rapid shift in focus from centralized laboratories to decentralized POC testing are also amongst the significant factors expected to fuel the growth of the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market.   

The rapid increase in the inclination of  end-user towards point-of-care  testing, rapid technological advancements and increase in the number of R&D are anticipated to offer significant growth opportunities for the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market in the forecast period of 2021 to 2028.

However, the unfavorable reimbursement scenario and changing regulatory landscape are expected to curb the growth of the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market, whereas the operational barriers can challenge the growth of the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market.

This over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Over the Counter (OTC)/Direct to Consumer (DTC) Infectious Disease Diagnostics Market Scope and Market Size

Over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market is segmented on the basis of technology, disease type and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

The technology segment of the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market is segmented into PCR, immunodiagnostics, clinical microbiology, INAAT, DNA sequencing and NGS, DNA microarrays and others.

  • Based on disease type, the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market is segmented into COVID-19, HIV, HAIs, hepatitis, CT/NG, HPV, TB, influenza and others,
  • On the basis of end user, the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, academic research institutes and others.

Over the Counter (OTC)/Direct to Consumer (DTC) Infectious Disease Diagnostics Market Country Level Analysis

Over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market is analyzed and market size insights and trends are provided by country, technology, disease type and end user as referenced above.

The countries covered in the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market owing to the well developed healthcare system in the US and Canada and strong presence of many leading national clinical laboratories. 

The country section of the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Over the Counter (OTC)/Direct to Consumer (DTC) Infectious Disease Diagnostics Market Share Analysis

Over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market.

The major players covered in the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market report are Abbott, Bio-Rad Laboratories Inc., BD, Bosch Healthcare Solutions GmbH, Danaher, ThermoFisher Scientific, Inc., Siemens AG, F. Hoffmann-La Roche AG, Hologic, Inc., Qiagen, Cardinal Health, Quest Diagnostics Incorporated, Ador Diagnostics, Akonni Biosystems, Inc., Alveo Technologies, Binx Health Inc., bioMérieux, Inc., Curetis, Sysmex Europe GmbH and Diasorin S.p.A., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market size will be worth USD 2,331.14 million by 2028.
The growth rate of the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market is 12.23% by 2030.
The rise in the focus on R&D and funding in infectious disease diagnostics and rise in the awareness for early disease diagnosis in developing countries are the growth drivers of the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market.
Technology, disease type, and end user are the factors on which the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market research is based.
Major companies in the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market are Abbott, Bio-Rad Laboratories Inc., BD, Bosch Healthcare Solutions GmbH, Danaher, ThermoFisher Scientific, Inc., Siemens AG, F. Hoffmann-La Roche AG, Hologic, Inc., Qiagen, Cardinal Health, Quest Diagnostics Incorporated, Ador Diagnostics, Akonni Biosystems, Inc., Alveo Technologies, Binx Health Inc., bioMérieux, Inc., Curetis, Sysmex Europe GmbH and Diasorin S.p.A.,
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials